| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 119.21▼ | 118.96▲ | 119.01▲ | 117.69▲ | 116.40▲ |
| MA10 | 119.27▼ | 118.96▲ | 118.79▲ | 114.18▲ | 112.90▲ |
| MA20 | 119.07▲ | 118.79▲ | 118.28▲ | 115.25▲ | 110.28▲ |
| MA50 | 118.99▲ | 117.76▲ | 115.60▲ | 112.21▲ | 117.36▲ |
| MA100 | 118.84▲ | 115.26▲ | 114.27▲ | 110.90▲ | 117.31▲ |
| MA200 | 118.35▲ | 114.40▲ | 114.49▲ | 118.79▲ | 130.48▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.056▼ | -0.089▼ | 0.449▲ | 1.331▲ |
| RSI | 53.425▲ | 58.253▲ | 61.780▲ | 60.684▲ | 54.080▲ |
| STOCH | 35.974 | 40.967 | 51.775 | 89.652▲ | 75.654 |
| WILL %R | -51.366 | -40.598 | -40.385 | -7.852▲ | -7.852▲ |
| CCI | -12.915 | 64.418 | 88.434 | 125.289▲ | 159.392▲ |
|
Sunday, August 17, 2025 08:35 PM
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the pharmaceuticals industry, including Jazz Pharmaceuticals (NASDAQ:JAZZ) and its ...
|
|
Sunday, August 17, 2025 08:35 PM
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the pharmaceuticals industry, including Jazz Pharmaceuticals (NASDAQ:JAZZ) and its ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 19/08/25 | 118.05 | 120.41 | 117.70 | 119.20 | 888,500 |
| 18/08/25 | 117.77 | 119.00 | 117.10 | 117.67 | 701,900 |
| 15/08/25 | 117.15 | 118.17 | 116.53 | 117.77 | 490,600 |
| 14/08/25 | 116.79 | 116.98 | 115.12 | 116.67 | 544,600 |
| 13/08/25 | 113.10 | 117.21 | 112.49 | 117.12 | 1,332,700 |
| 12/08/25 | 111.26 | 113.42 | 110.26 | 113.33 | 772,600 |
| 11/08/25 | 111.49 | 113.54 | 110.26 | 110.75 | 607,000 |
| 08/08/25 | 111.25 | 112.32 | 109.87 | 111.30 | 893,700 |
| 07/08/25 | 107.67 | 112.40 | 106.65 | 112.08 | 1,601,000 |
| 06/08/25 | 107.55 | 113.04 | 105.00 | 105.93 | 2,570,000 |
|
|
||||
|
|
||||
|
|